Clinical trial
Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive…
NCT00383578 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00383578 |
|---|---|
| Title | Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes |
| Official title | A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 24 Weeks Treatment With Vildagliptin 100 mg qd or Metformin 1500 mg Daily in Elderly Drug Naive Patients With Type 2 Diabetes |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Vildagliptin 100 mg qd, Metformin 1500 mg daily |
| Enrollment | 335 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2008 |
| First posted | Oct 3, 2006 |
| Last update posted | Dec 17, 2020 |
| Countries | Germany, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: